WHO recommendation Serum Institute of India Pvt Ltd - COVID-19 Vaccine (ChAdOx1-S [recombinant]) - COVISHIELD™
Product Overview |
|||
Vaccine type: | COVID-19 Vaccine (ChAdOx1-S ([recombinant]) | ||
Commercial name: | COVISHIELD™ | ||
EUL holder: | Serum Institute of India Pvt. Ltd | ||
Country: | India | ||
URL: | https://www.seruminstitute.com/ | ||
Manufacturing sites: | See box below "Manufacturing sites" | ||
Responsible NRA: | Central Drugs Standard Control Organization | ||
Country: | India | ||
URL: | https://cdsco.gov.in/opencms/opencms/en/Home/ | ||
WHO Recommendation |
|||
Effective date: | 15 February 2021 | ||
Product Description |
|||
Pharmaceutical form: | Solution for injection | ||
Presentation: | Vial | ||
Number of doses: | 2 and 10 doses | ||
Diluent: | Not applicable | ||
Route of administration: | Intramuscular | ||
Age indication: | Individuals aged 18 years and older | ||
Shelf-life: | 9 months | at storage temperature: | 2°C to 8°C |
Vaccine vial monitor: | None | ||
Secondary packaging: | COVIDSHIELD-2dose: Carton holds 50 vaccine vials (100 doses) Dimensions: 18.5 x 9.5 x 4.0 cm COVIDSHIELD-10 dose: Carton holds 50 vaccine vials (500 doses) |
||
Tertiary packaging: | COVIDSHIELD-2dose: 6 secondary packaged cartons containing 50 vials per carton (300 vials /600 doses): Dimensions: 31.0 x 19.0 x 9.3 cm COVIDSHIELD-10 dose: 6 secondary packaged cartons containing 50 vials per carton (300 vials /3000 doses): Dimensions: 31.0 x 19.0 x 9.3 cm |
||
Cold chain volume: | 7.03 (2 dose vial) 2.109 (10 dose vial) |
cm3 (in secondary packaging) | |
Preservative: | Not applicable | with concentration: | Not applicable |
Handling of opened multidose-vials: | WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first. |